CYP46A1
Cholesterol 24-hydroxylase
Also known as: CP46A_HUMAN, CYP46
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y6A2
- Gene
- CYP46A1
- Ensembl
- ENSG00000036530
- Chromosome
- 14
- Canonical length
- 500 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This endoplasmic reticulum protein is expressed in the brain, where it converts cholesterol to 24S-hydroxycholesterol. While cholesterol cannot pass the blood-brain barrier, 24S-hydroxycholesterol can be secreted in the brain into the circulation to be returned to the liver for catabolism. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
500 residues, UniProt reviewed canonical sequence.
>Q9Y6A2|CYP46A1
1 MSPGLLLLGS AVLLAFGLCC TFVHRARSRY EHIPGPPRPS FLLGHLPCFW KKDEVGGRVL
61 QDVFLDWAKK YGPVVRVNVF HKTSVIVTSP ESVKKFLMST KYNKDSKMYR ALQTVFGERL
121 FGQGLVSECN YERWHKQRRV IDLAFSRSSL VSLMETFNEK AEQLVEILEA KADGQTPVSM
181 QDMLTYTAMD ILAKAAFGME TSMLLGAQKP LSQAVKLMLE GITASRNTLA KFLPGKRKQL
241 REVRESIRFL RQVGRDWVQR RREALKRGEE VPADILTQIL KAEEGAQDDE GLLDNFVTFF
301 IAGHETSANH LAFTVMELSR QPEIVARLQA EVDEVIGSKR YLDFEDLGRL QYLSQVLKES
361 LRLYPPAWGT FRLLEEETLI DGVRVPGNTP LLFSTYVMGR MDTYFEDPLT FNPDRFGPGA
421 PKPRFTYFPF SLGHRSCIGQ QFAQMEVKVV MAKLLQRLEF RLVPGQRFGL QEQATLKPLD
481 PVLCTLRPRG WQPAPPPPPCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CYP46A1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 159 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 159 nTPM
- cerebral cortex: 88 nTPM
- hippocampal formation: 61 nTPM
- amygdala: 53 nTPM
- hypothalamus: 37 nTPM
- midbrain: 26 nTPM
Single-cell type
- somatotrophs: 163 nCPM
- brain inhibitory neurons: 135 nCPM
- thyrotrophs: 102 nCPM
- pdcs: 96 nCPM
- cone photoreceptor cells: 95 nCPM
- astrocytes: 89 nCPM
Immune cell
- plasmacytoid DC: 3.4 nTPM
- memory CD8 T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- basal ganglia: 183 nTPM
- cerebral cortex: 99 nTPM
- hippocampal formation: 92 nTPM
- amygdala: 74 nTPM
- thalamus: 63 nTPM
- white matter: 62 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.3
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 2.97
- DepMap mean gene effect
- 0.12
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- bile acid biosynthetic process
- cholesterol catabolic process
- nervous system development
- progesterone metabolic process
- protein localization to membrane raft
- regulation of long-term synaptic potentiation
- sterol metabolic process
- xenobiotic metabolic process
Molecular functions
- heme binding
- iron ion binding
- steroid hydroxylase activity
- testosterone 16-beta-hydroxylase activity
- testosterone 6-beta-hydroxylase activity
- cholesterol 24-hydroxylase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CYP46A1 as an antibody target. Whether an autoantibody or antibody against CYP46A1 could matter depends on whether native CYP46A1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CYP46A1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CYP46A1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...